Nutritional intervention with a bioactive food compound in hiv/ aids patients with hypertriglyceridemia: case reports

Introduction: The Highly Active Antiretroviral Therapy (HAART) in individuals infected by the Human Immunodeficiency Virus (HIV) may provide changes in lipid metabolism, increasing the risk of cardiovascular diseases. Objective: To evaluate the clinical and nutritional status by laboratory tests, anthropometry and food consumption, proposing nutritional intervention with a Bioactive Food Compound (BFC). Material and Methods: Clinical case reports of two patients in outpatient care at a referral hospital; approved by the Ethics Committee/Universidade Federal de Mato Grosso do Sul (UFMS), number 1630, with signing of the informed consent form. Patients, male, 45 e 40 years old, with infection by HIV, diagnostic of Acquired Immunodeficiency Syndrome (AIDS) and hypertriglyceridemia, in use of medication to control of triglycerides (TG) and HAART containing medications with side effects for dyslipidemia. Results: It was observed in both cases in the end of 210 days, eutrophy, body mass index (BMI) (20.54/20.80 kg/m2), waist circumference (WC) (87/79 cm) and conicity index (CI) (1.33/1.25), controlled levels of TG (79/83 mg/dL). In the begin of study the patients presented low ingest of micronutrients and fibers, beyond of high concentration of simple and complex carbohydrates. It was proposed to lifestyle changes (LC), restriction of foods that predispose to hypercholesterolemia, hypertriglyceridemia, hyperglycemia and physical activity. During 210 days were evaluated with use of BFC, containing oat bran, flaxseed and textured soy protein; with potential contribution to the control of atherosclerotic diseases. The potential contribution to the control of atherosclerotic diseases, nutritional goals reached and TG reduced, with medication suspension ciprofibrate. Were maintained the recommendations of LC and diary consume of 40 g of BFC.